TOBI^® (Tobramycin Inhalation Solution, USP)    is made specifically to treat bacteria    called Pseudomonas aeruginosa   in the lungs. Chronic Pseudomonas aeruginosa infections are the
main cause of declining lung function in people with cystic fibrosis. When TOBI is taken using the
FDA-approved nebulizer    and compressor   , it goes into the lungs and reaches the infected areas.

When taken as directed, TOBI can improve lung function, decrease the concentration of
Pseudomonas aeruginosa in sputum   , and reduce the length of hospital stays.